YOU ARE HERE: LAT HomeCollectionsBlood Clots

Blood Clots

September 5, 2008 | From Times Wire Services
Federal regulators say a drug from Pfizer Inc. and Ligand Pharmaceuticals Inc. effectively treats osteoporosis, but they are concerned about deaths, blood clots and other problems seen in company studies. The Food and Drug Administration noted that women treated with Pfizer's Fablyn were more likely to die of cancer or stroke than those taking a placebo. The FDA posted its review of the drug online in advance of a meeting Monday with outside advisors.
December 13, 2007 | Tiffany Hsu, Times Staff Writer
A Catalina Island woman was acquitted Wednesday of murdering her newborn daughter and stuffing the body into a trash container, in the second rebuff this month to Los Angeles County prosecutors seeking criminal convictions for baby dumping. Leticia Castro sobbed loudly and thanked the jury for its decision in the 2004 case, said Jay Glaser, her attorney.
July 30, 2007 | Chelsea Martinez, Times Staff Writer
BLOOD clots can be painful, difficult to diagnose, even life-threatening. But hospital patients -- who are at an especially high risk of developing the condition -- often don't receive treatment to prevent them, researchers have found. A hospital stay, even one as short as a few days, can greatly increase the chance of developing a clot in the legs or lungs. In fact, blood clots in the lungs, known as pulmonary embolisms, are blamed for as much as 10% of deaths in hospitalized patients.
March 6, 2007 | James Gerstenzang and Thomas H. Maugh II, Times Staff Writers
Vice President Dick Cheney is being treated for a blood clot in his left leg, his office announced Monday -- a condition that, if left untreated, can be deadly if the clot breaks loose and reaches the heart, brain or lungs. The vice president, who has had four heart attacks and experienced other cardiovascular problems over the last three decades, is being treated with blood-thinning medication, said his deputy press secretary, Megan McGinn.
January 21, 2007 | Linda A. Johnson, Associated Press Writer
Personalized medicine, the tailored treatments that a few patients get based on their own DNA, is finally headed for the masses: the many heart patients at risk of deadly blood clots. At least 2 million Americans with an abnormal, clot-triggering heart rhythm take the pill warfarin, also sold as Coumadin. Getting too little can lead to a stroke, and too much can cause life-threatening bleeding.
November 30, 2006 | Robert Little, The Baltimore Sun
Two senators called on the Pentagon on Wednesday to investigate the military's use of a largely experimental blood-coagulating drug that doctors inject into wounded troops to control bleeding, but which has been linked to unexpected and potentially deadly blood clots. Sen. Barbara A. Mikulski (D-Md.) sent a letter to Dr. William Winkenwerder Jr., assistant secretary of Defense for health affairs, asking him to launch an investigation into use of the drug, called Recombinant Activated Factor VII.
November 10, 2006 | From the Associated Press
Carolina defensive tackle Jordan Carstens remained hospitalized Thursday in Charlotte, N.C., as doctors treated a blood clot on his left lung. Carstens was sent to the hospital Wednesday after complaining of chest pain just before practice began. "Kudos to our medical people," Panthers Coach John Fox said. "He had some chest pain and that's all we thought it was. Luckily [trainer] Ryan [Vermillion] and our doctors were very cautious and sent him to the hospital.
August 28, 2006 | From Times wire reports
Injections of the blood thinner heparin treat blood clots just as effectively as a top-selling version that is far more expensive, researchers said Tuesday. To treat deep vein thrombosis, which appears most often as blood clots in the legs, injections of low-molecular weight heparin such as Sanofi-Aventis' blockbuster Lovenox and Pfizer's Fragmin have been increasingly seen as more convenient and effective than regular heparin.
August 24, 2006 | Amanda Covarrubias, Times Staff Writer
Two months after the unexpected death of the Los Angeles Zoo's female Asian elephant, a necropsy concluded Wednesday that Gita died of cardiac failure associated with blood clots. However, veterinary pathologists could not determine why she became lame and went into a down position in her enclosure. Nor could they say whether the hours that passed before she was discovered in the prone position and the time she received medical treatment contributed to her death.
August 21, 2006 | From the Associated Press
Tom Glavine's pitching shoulder is being examined for a possible blood clot, and the New York Mets left-hander could sit out the rest of the season. Glavine felt coldness in his left ring finger after his start Wednesday in Philadelphia. Depending on tests, the 40-year-old pitcher could return to the mound next weekend or require surgery. The Mets don't expect to receive test results until midweek. "You get scared.
Los Angeles Times Articles